Celldex Therapeutics CLDX
NASDAQ CLDX
$30.47 -0.18 (-0.59%)
As of: Nov 11, 2026 · 2:31 PM EST

Celldex Therapeutics (CLDX) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Celldex Therapeutics (CLDX) reported Return on Capital Employed [ROCE] of -55.65% for Q2 2026, down 21.28 percentage points from -34.37% a year earlier but up 6.70 percentage points from the prior quarter.

Analysis

Celldex Therapeutics (CLDX) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2025, Celldex Therapeutics posted Return on Capital Employed [ROCE] of -45.14%, down 12.04 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of -6.78 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -33.09% in FY2024 (+7.78 pp), -40.88% in FY2023 (-10.56 pp), -30.32% in FY2022 (-8.31 pp) and -22.01% in FY2021 (+16.35 pp).
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -62.36% in Q1 2026 and a high of -16.34% in Q4 2021.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last six quarters, with an average year-over-year change of -8.34 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2024 (a gain of 28.19 percentage points); the low point was Q1 2026 (a drop of 32.76 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -62.36% (Q1 2026), -50.89% (Q4 2025) and -41.07% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Celldex Therapeutics 2.41 Bn 69.14 Mn - -48.37%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -48.37%
Jun 30, 2026 -55.65%
Mar 31, 2026 -62.36%
Dec 31, 2025 -50.89%
Sep 30, 2025 -41.07%
Jun 30, 2025 -34.37%
Mar 31, 2025 -29.60%
Dec 31, 2024 -25.39%
Sep 30, 2024 -23.27%
Jun 30, 2024 -21.19%
Mar 31, 2024 -25.38%
Dec 31, 2023 -45.21%
Sep 30, 2023 -51.46%
Jun 30, 2023 -40.93%
Mar 31, 2023 -38.48%
Dec 31, 2022 -33.66%
Sep 30, 2022 -29.12%
Jun 30, 2022 -26.29%
Mar 31, 2022 -18.55%
Dec 31, 2021 -16.34%
API Access

Celldex Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CLDX&period=max&api_key=YOUR_API_KEY